Modification Strategies of Lipid-Based Nanocarriers for Mucosal Drug Delivery

E-ISSN： 1873-4286|21|36|5198-5211

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.36, 2015-11, pp. : 5198-5211

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid-Based Nanocarriers for RNA Delivery

Current Pharmaceutical Design, Vol. 21, Iss. 22, 2015-01 ,pp. : 3140-3147

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-based Nanocarriers As An Alternative for Oral Delivery of Poorly Water- Soluble Drugs: Peroral and Mucosal Routes

Current Medicinal Chemistry, Vol. 19, Iss. 26, 2012-09 ,pp. : 4495-4510

Bentham Science Publishers

Access to resources Recommend Favorite

Lipid-based nanocarriers for drug delivery and targeting: a patent survey of methods of production and characterization

By Carbone Claudia Cupri Sarha Leonardi Antonio Puglisi Giovanni Pignatello Rosario

Pharmaceutical Patent Analyst, Vol. 2, Iss. 5, 2013-09 ,pp. : 665-677

Future Science

Access to resources Recommend Favorite

Phospholipids and Lipid-Based Formulations in Oral Drug Delivery

By Fricker Gert Kromp Torsten Wendel Armin Blume Alfred Zirkel Jürgen Rebmann Herbert Setzer Constanze Quinkert Ralf-Olaf Martin Frank Müller-Goymann Christel

Pharmaceutical Research, Vol. 27, Iss. 8, 2010-08 ,pp. : 1469-1486

Springer Publishing Company

Access to resources Recommend Favorite

Lipid-Based Drug Delivery Systems for Cancer Treatment

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1151-1165

Bentham Science Publishers

Access to resources Recommend Favorite